Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 216.60 INR
Change Today +25.85 / 13.55%
Volume 678.2K
As of 7:06 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

vivimed labs ltd (VILA) Snapshot

Open
195.00
Previous Close
190.75
Day High
229.40
Day Low
192.70
52 Week High
12/1/14 - 435.40
52 Week Low
06/24/15 - 175.00
Market Cap
3.5B
Average Volume 10 Days
220.4K
EPS TTM
44.47
Shares Outstanding
16.2M
EX-Date
09/24/14
P/E TM
4.9x
Dividend
--
Dividend Yield
1.39%
Current Stock Chart for VIVIMED LABS LTD (VILA)

Related News

No related news articles were found.

vivimed labs ltd (VILA) Related Businessweek News

No Related Businessweek News Found

vivimed labs ltd (VILA) Details

Vivimed Labs Limited, together with its subsidiaries, manufactures specialty chemicals and pharmaceutical products in India and internationally. It operates through two segments, Speciality Chemicals and Pharmaceuticals. The company offers contractual manufacturing services for APIs and formulations, as well as active ingredients for a range of home, personal care, and industrial products; and manufactures branded formulations. Its products include antibacterials for toothpaste and mouthwash, and neutraceuticals for dental enamel protection for the oral care market; UV-A and UV-B filters for sun care products; skin care ingredients, such as active anti-wrinkle, anti-ageing compounds, anti-oxidants, skin-lightening actives, and emollients; hair dye intermediates, anti-dandruff agents, UV absorbers, hair loss actives, and guar gums for use in hair care products. The company also provides Reversacol photochromic dyes for applications in plastics, films, coatings, and inks; anti-microbial actives for use in a range of applications, such as plastics additives and anti-bacterial hand washes; preservatives for various formulations; photographic chemicals for use in the medical and industrial X-ray imaging, consumer photography, and litho-plate production for the graphic arts industry; and Nisarg range of naturally derived cosmetic ingredients. In addition, it offers ophthalmic, nutraceuticals, and dermatological therapeutic products. Vivimed Labs Limited was incorporated in 1988 and is based in Hyderabad, India.

Founded in 1988

vivimed labs ltd (VILA) Top Compensated Officers

Director of Research & Development and Direct...
Total Annual Compensation: 2.4M
Compensation as of Fiscal Year 2013.

vivimed labs ltd (VILA) Key Developments

Vivimed Labs Limited Reports Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Vivimed Labs Limited reported audited standalone and consolidated earnings results for the fourth quarter and year ended March 31, 2015. For the quarter on standalone basis, net sales/income from operation was INR 3,562.152 million against INR 3,681.732 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 397.206 million against INR 412.951 million a year ago. Profit from ordinary activities before tax was INR 163.478 million against INR 236.602 million a year ago. Net profit was INR 179.482 million or INR 11.08 per basic and diluted share against INR 110.417 million or INR 6.81 per basic and diluted share a year ago. For the year on standalone basis, net sales/income from operation was INR 13,800.991 million against INR 13,508.330 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 1,565.741 million against INR 1,471.526 million a year ago. Profit from ordinary activities before tax was INR 775.373 million against INR 868.616 million a year ago. Net profit was INR 720.504 million or INR 44.47 per basic and diluted share against INR 663.941 million or INR 40.97 per basic and diluted share a year ago. For the quarter on consolidated basis, net sales/income from operation was INR 1,264.127 million against INR 1,278.101 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 227.495 million against INR 260.424 million a year ago. Profit from ordinary activities before tax was INR 67.497 million against INR 111.159 million a year ago. Net profit was INR 55.977 million or INR 3.45 per basic and diluted share against INR 44.761 million or INR 2.76 per basic and diluted share a year ago. For the year on consolidated basis, net sales/income from operation was INR 4,301.481 million against INR 4,319.935 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 865.904 million against INR 831.512 million a year ago. Profit from ordinary activities before tax was INR 242.551 million against INR 388.073 million a year ago. Net profit was INR 189.352 million or INR 11.69 per basic and diluted share against INR 266.292 million or INR 16.43 per basic and diluted share a year ago.

Vivimed Labs Limited to Report Fiscal Year 2015 Results on May 30, 2015

Vivimed Labs Limited announced that they will report fiscal year 2015 results on May 30, 2015

Vivimed Labs Limited, Board Meeting, May 30, 2015

Vivimed Labs Limited, Board Meeting, May 30, 2015. Agenda: To consider and approve the audited financial results of the company for the financial year ended March 31, 2015; and to recommend dividend, if any, for the financial year 2014-15.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VILA:IN 216.60 INR 0.00

VILA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VILA.
View Industry Companies
 

Industry Analysis

VILA

Industry Average

Valuation VILA Industry Range
Price/Earnings 4.7x
Price/Sales 0.2x
Price/Book 0.7x
Price/Cash Flow 2.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVIMED LABS LTD, please visit www.vivimedlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.